Related Experiment Video
Updated: Jul 5, 2026
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Platelet-activating factor (PAF) increases NO production in human endothelial cells-real-time monitoring by DAR-4M AM
M Kikuchi1, H Shirasaki, T Himi
1Department of Otolaryngology, Sapporo Medical University, School of Medicine, S-1 W-16 Chuo-ku, Sapporo, Japan. mkikuchi@sapmed.ac.jp
Background:
Platelet-activating factor (PAF) is a potent inflammatory lipid mediator that increases vascular permeability and vasodilation. Several studies have addressed the effect of PAF on nitric oxide (NO) production from microvessels in vivo.
Objective:
The aim of present study was to evaluate the effect of PAF on NO production in primary cultured human vascular endothelial cells.
Methods:
Human umbilical vein endothelial cells (HUVECs) were loaded with diaminorhodamine-4M acetoxymethyl ester (DAR-4MAM), and the cells were stimulated with PAF. Intracellular NO production was monitored as increase in fluorescence intensity. Also, NO production was visualized at cellular levels using DAR-4M AM and fluorescence imaging.
Results:
Significant increases in NO production in HUVECs were soon after the PAF stimulation, reaching a plateau after 10 min of the stimulation. The increase of NO production at 10 min after the stimulation was statistically significant (p<0.05) for 0.01-10 microM PAF. PAF-induced NO production was abolished by pretreatment of HUVECs with a NOS inhibitor N(G)-monomethyl-L-arginine (L-NMMA) or PAF receptor antagonist BN 52021. LysoPAF, the inactive metabolite of PAF, did not exert a significant effect on intracellular NO levels.
Conclusions:
These results provide direct evidence that PAF cause intracellular NO production via activation of PAF receptors in human vascular endothelial cells.
